Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum

In vivo Efficacy and Pharmacokinetics of Optimized Apidaecin Analogs

(2017) Rico Schmidt et al.   Frontiers in Chemistry

Pharmacokinetics andin vivoefficacy of optimized oncocin derivatives

(2016) Rico Schmidt et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Readily adaptable release kinetics of prodrugs using protease-dependent reversible PEGylation

(2016) Roland Böttger et al.   JOURNAL OF CONTROLLED RELEASE

Proline-rich Antimicrobial Peptides Optimized for Binding to Escherichia coli Chaperone DnaK

(2016) Daniel Knappe et al.   PROTEIN AND PEPTIDE LETTERS

Structure-Activity Relationship Study of Novel Peptoids That Mimic the Structure of Antimicrobial Peptides

(2015) Biljana Mojsoska et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Twenty years of theMEROPSdatabase of proteolytic enzymes, their substrates and inhibitors

(2015) Neil D. Rawlings et al.   NUCLEIC ACIDS RESEARCH

Insect-Derived Proline-Rich Antimicrobial Peptides Kill Bacteria by Inhibiting Bacterial Protein Translation at the 70 S Ribosome

(2014) Andor Krizsan et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Fundamental Molecular Mechanism for the Cellular Uptake of Guanidinium-Rich Molecules

(2014) Henry D. Herce et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Hydroxyproline Substitutions Stabilize Non-Glycosylated Drosocin Against Serum Proteases Without Challenging its Antibacterial Activity

(2014) Daniel Knappe et al.   PROTEIN AND PEPTIDE LETTERS

Sample collection in clinical proteomics-Proteolytic activity profile of serum and plasma

(2014) Kalyani Jambunathan et al.   Proteomics Clinical Applications

Api88 Is a Novel Antibacterial Designer Peptide To Treat Systemic Infections with Multidrug-Resistant Gram-Negative Pathogens

(2012) Patricia Czihal et al.   ACS Chemical Biology

Intracellular Toxicity of Proline-Rich Antimicrobial Peptides Shuttled into Mammalian Cells by the Cell-Penetrating Peptide Penetratin

(2012) Anne Hansen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Novel Apidaecin 1b Analogs with Superior Serum Stabilities for Treatment of Infections by Gram-Negative Pathogens

(2012) Nicole Berthold et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Targeting the S1 and S3 Subsite of Trypsin with Unnatural Cationic Amino Acids Generates Antimicrobial Peptides with Potential for Oral Administration

(2012) Rasmus Karstad et al.   JOURNAL OF MEDICINAL CHEMISTRY

Easy Strategy To Protect Antimicrobial Peptides from Fast Degradation in Serum

(2010) D. Knappe et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Chemical Modifications Designed to Improve Peptide Stability: Incorporation of Non-Natural Amino Acids, Pseudo-Peptide Bonds, and Cyclization

(2010) Luca Gentilucci et al.   CURRENT PHARMACEUTICAL DESIGN

Bactericidal oncocin derivatives with superior serum stabilities

(2010) Daniel Knappe et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): A Novel Antibacterial Peptide Optimized against Gram-Negative Human Pathogens

(2010) Daniel Knappe et al.   JOURNAL OF MEDICINAL CHEMISTRY

Blood Coagulation: Hemostasis and Thrombin Regulation

(2009) Kenichi A. Tanaka et al.   ANESTHESIA AND ANALGESIA

Substitution of the Arginine/Leucine Residues in Apidaecin Ib with Peptoid Residues: Effect on Antimicrobial Activity, Cellular Uptake, and Proteolytic Degradation

(2009) Marina Gobbo et al.   JOURNAL OF MEDICINAL CHEMISTRY

RECENT ADVANCES IN HAEMOSTASIS AND THROMBOSIS

(2009) ANDREW K. VINE   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Influence of the surface on thrombin generation

(2007) T. W. STIEF   International Journal of Laboratory Hematology